Granules India Ltd share price was up by 2.77% from the previous closing price of ₹568.00. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals Industries ...

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical’s products segment. Its geographical segments include within India ...

F&O ban list: The National Stock Exchange (NSE) banned trading in five stocks on Tuesday, December 24, in the futures and options (F&O) segment, as they exceeded 95 per cent of the market-wide ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 14,045.24 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

Jan 13, 2025 11:16 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis.

Nifty futures closed at 25,478 on Thursday with a loss of 1.89%. Experts recommend short-term buys in stocks like Dalmia Bharat, Angel One, Granules India, Cipla, TCS, Jubilant Pharmova, HDFC Bank, ...